{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:20:20Z","timestamp":1790742020307,"version":"4.1.0"},"reference-count":70,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,2,23]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>CML progenitor cells demonstrate enhanced sensitivity to Wnt stimulation, related to increased FZD4 receptor expression. Wnt inhibition by a Porcupine acyl transferase inhibitor enhances CML stem\/progenitor cell targeting in combination with tyrosine kinase inhibition.<\/jats:p>","DOI":"10.1182\/blood-2016-05-714089","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T22:00:30Z","timestamp":1482530430000},"page":"1008-1020","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":66,"title":["Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI"],"prefix":"10.1182","volume":"129","author":[{"given":"Puneet","family":"Agarwal","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Hematopoietic Stem Cell and Leukemia Research, City of Hope National Medical Center, Duarte, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinwei","family":"Ho","sequence":"additional","affiliation":[{"name":"Division of Hematopoietic Stem Cell and Leukemia Research, City of Hope National Medical Center, Duarte, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Cook","sequence":"additional","affiliation":[{"name":"Division of Hematopoietic Stem Cell and Leukemia Research, City of Hope National Medical Center, Duarte, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Hematopoietic Stem Cell and Leukemia Research, City of Hope National Medical Center, Duarte, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady M.","family":"Mikhail","sequence":"additional","affiliation":[{"name":"Department of Genetics, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youzhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Oncology Disease Area, Novartis Institute of Biomedical Research, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Oncology Disease Area, Novartis Institute of Biomedical Research, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"17","key":"2019111903441765600_B1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N Engl J Med"},{"issue":"23","key":"2019111903441765600_B2","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"2019111903441765600_B3","article-title":"Second-generation BCR-ABL kinase inhibitors in CML","author":"Tanimoto"},{"issue":"11","key":"2019111903441765600_B4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol"},{"issue":"8","key":"2019111903441765600_B5","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2003-04-1271","article-title":"BCR\/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells","volume":"103","author":"Chu","year":"2004","journal-title":"Blood"},{"issue":"20","key":"2019111903441765600_B6","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2019111903441765600_B7","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"issue":"1","key":"2019111903441765600_B8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111903441765600_B9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI28568","article-title":"The stem cell niches in bone","volume":"116","author":"Yin","year":"2006","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111903441765600_B10","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood-2009-01-202606","article-title":"The leukemic stem cell niche: current concepts and therapeutic opportunities","volume":"114","author":"Lane","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2019111903441765600_B11","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1080\/10428190903150847","article-title":"Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to imatinib and nilotinib","volume":"50","author":"Dillmann","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2019111903441765600_B12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.leukres.2011.12.002","article-title":"Potentiation of nilotinib-mediated cell death in the context of the bone marrow microenvironment requires a promiscuous JAK inhibitor in CML","volume":"36","author":"Nair","year":"2012","journal-title":"Leuk Res"},{"issue":"2","key":"2019111903441765600_B13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.leukres.2013.11.006","article-title":"Selective strong synergism of ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia","volume":"38","author":"Quintarelli","year":"2014","journal-title":"Leuk Res"},{"issue":"5","key":"2019111903441765600_B14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/leu.2011.360","article-title":"Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib","volume":"26","author":"Weisberg","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"2019111903441765600_B15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev Cell"},{"issue":"25","key":"2019111903441765600_B16","doi-asserted-by":"crossref","first-page":"E2298","DOI":"10.1073\/pnas.1301838110","article-title":"Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function","volume":"110","author":"Lim","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019111903441765600_B17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2012.02.017","article-title":"Genetic and pharmacologic inhibition of \u03b2-catenin targets imatinib-resistant leukemia stem cells in CML","volume":"10","author":"Heidel","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2019111903441765600_B18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","article-title":"beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia","volume":"23","author":"Hu","year":"2009","journal-title":"Leukemia"},{"issue":"10","key":"2019111903441765600_B19","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1182\/blood-2011-03-345165","article-title":"Differential niche and Wnt requirements during acute myeloid leukemia progression","volume":"118","author":"Lane","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111903441765600_B20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/leu.2011.387","article-title":"Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development","volume":"26","author":"Luis","year":"2012","journal-title":"Leukemia"},{"key":"2019111903441765600_B21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1749-6632.2009.04566.x","article-title":"WNT proteins: environmental factors regulating HSC fate in the niche","volume":"1176","author":"Luis","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2019111903441765600_B22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/stem.32","article-title":"beta-Catenin expression in the bone marrow microenvironment is required for long-term maintenance of primitive hematopoietic cells","volume":"27","author":"Nemeth","year":"2009","journal-title":"Stem Cells"},{"key":"2019111903441765600_B23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.12384","article-title":"Regulation of hematopoiesis by activators and inhibitors of Wnt signaling from the niche","volume":"1310","author":"Schreck","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2019111903441765600_B24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cell.2012.05.041","article-title":"Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche","volume":"150","author":"Sugimura","year":"2012","journal-title":"Cell"},{"issue":"5973","key":"2019111903441765600_B25","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","article-title":"The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"issue":"6","key":"2019111903441765600_B26","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/stem.52","article-title":"Identification of a stroma-mediated Wnt\/beta-catenin signal promoting self-renewal of hematopoietic stem cells in the stem cell niche","volume":"27","author":"Kim","year":"2009","journal-title":"Stem Cells"},{"issue":"2","key":"2019111903441765600_B27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.20031615","article-title":"Beta-catenin is dispensable for hematopoiesis and lymphopoiesis","volume":"199","author":"Cobas","year":"2004","journal-title":"J Exp Med"},{"issue":"6","key":"2019111903441765600_B28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"},{"issue":"7","key":"2019111903441765600_B29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111903441765600_B30","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1073\/pnas.0900189106","article-title":"Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation","volume":"106","author":"Abrahamsson","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019111903441765600_B31","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.emboj.7601485","article-title":"Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation","volume":"26","author":"Coluccia","year":"2007","journal-title":"EMBO J"},{"issue":"10","key":"2019111903441765600_B32","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2011-06-361261","article-title":"Targeting of GSK3\u03b2 promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells","volume":"119","author":"Reddiconto","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2019111903441765600_B33","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-\u03b2-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"issue":"24","key":"2019111903441765600_B34","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1101\/gad.10.24.3116","article-title":"The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in Wingless processing","volume":"10","author":"Kadowaki","year":"1996","journal-title":"Genes Dev"},{"issue":"2","key":"2019111903441765600_B35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ydbio.2011.11.003","article-title":"Porcupine-mediated lipidation is required for Wnt recognition by Wls","volume":"361","author":"Herr","year":"2012","journal-title":"Dev Biol"},{"issue":"50","key":"2019111903441765600_B36","doi-asserted-by":"crossref","first-page":"20224","DOI":"10.1073\/pnas.1314239110","article-title":"Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974","volume":"110","author":"Liu","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"31","key":"2019111903441765600_B37","doi-asserted-by":"crossref","first-page":"12649","DOI":"10.1073\/pnas.1307218110","article-title":"Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma","volume":"110","author":"Jiang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019111903441765600_B38","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1365-2141.2003.04217.x","article-title":"Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase","volume":"120","author":"Mihara","year":"2003","journal-title":"Br J Haematol"},{"issue":"12","key":"2019111903441765600_B39","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1182\/blood.V85.12.3636.bloodjournal85123636","article-title":"Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages","volume":"85","author":"Bhatia","year":"1995","journal-title":"Blood"},{"key":"2019111903441765600_B40","author":"Biechele"},{"issue":"12","key":"2019111903441765600_B41","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019111903441765600_B42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","article-title":"Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia","volume":"21","author":"Zhang","year":"2012","journal-title":"Cancer Cell"},{"issue":"9","key":"2019111903441765600_B43","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1182\/blood-2003-03-0768","article-title":"Inducible expression of BCR\/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndrome","volume":"102","author":"Huettner","year":"2003","journal-title":"Blood"},{"issue":"1","key":"2019111903441765600_B44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","article-title":"Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis","volume":"105","author":"Koschmieder","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2019111903441765600_B45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/labinvest.2015.150","article-title":"Targeting the Wnt\/\u03b2-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974","volume":"96","author":"Boone","year":"2016","journal-title":"Lab Invest"},{"issue":"25","key":"2019111903441765600_B46","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2019111903441765600_B47","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Hamilton","year":"2012","journal-title":"Blood"},{"issue":"11","key":"2019111903441765600_B48","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/2159-8290.CD-16-0263","article-title":"Epigenetic reprogramming sensitizes CML stem cells to combined EZH2 and tyrosine kinase inhibition","volume":"6","author":"Scott","year":"2016","journal-title":"Cancer Discov"},{"issue":"10","key":"2019111903441765600_B49","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1172\/JCI68951","article-title":"PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells","volume":"123","author":"Neviani","year":"2013","journal-title":"J Clin Invest"},{"issue":"7607","key":"2019111903441765600_B50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"},{"issue":"23","key":"2019111903441765600_B51","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1182\/blood-2015-11-679928","article-title":"Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor-treated CML stem cells","volume":"128","author":"Zhang","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2019111903441765600_B52","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccr.2010.03.011","article-title":"Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate","volume":"17","author":"Zhang","year":"2010","journal-title":"Cancer Cell"},{"issue":"17","key":"2019111903441765600_B53","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2014-06-582924","article-title":"Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia development","volume":"125","author":"Bowers","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2019111903441765600_B54","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1172\/JCI79196","article-title":"Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells","volume":"126","author":"Zhang","year":"2016","journal-title":"J Clin Invest"},{"key":"2019111903441765600_B55","doi-asserted-by":"crossref","first-page":"25476","DOI":"10.1038\/srep25476","article-title":"Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia","volume":"6","author":"Irvine","year":"2016","journal-title":"Sci Rep"},{"issue":"11","key":"2019111903441765600_B56","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1242\/dev.104976","article-title":"Stroma provides an intestinal stem cell niche in the absence of epithelial Wnts","volume":"141","author":"Kabiri","year":"2014","journal-title":"Development"},{"issue":"6","key":"2019111903441765600_B57","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.devcel.2006.10.003","article-title":"Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion","volume":"11","author":"Takada","year":"2006","journal-title":"Dev Cell"},{"issue":"8","key":"2019111903441765600_B58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.molmed.2012.06.008","article-title":"WNT secretion and signalling in human disease","volume":"18","author":"Herr","year":"2012","journal-title":"Trends Mol Med"},{"issue":"6090","key":"2019111903441765600_B59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1126\/science.1222879","article-title":"Structural basis of Wnt recognition by Frizzled","volume":"337","author":"Janda","year":"2012","journal-title":"Science"},{"issue":"3","key":"2019111903441765600_B60","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1042\/BJ20061476","article-title":"Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling","volume":"402","author":"Kurayoshi","year":"2007","journal-title":"Biochem J"},{"issue":"2","key":"2019111903441765600_B61","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nchembio.137","article-title":"Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer","volume":"5","author":"Chen","year":"2009","journal-title":"Nat Chem Biol"},{"issue":"2","key":"2019111903441765600_B62","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1158\/0008-5472.CAN-12-2258","article-title":"Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer","volume":"73","author":"Proffitt","year":"2013","journal-title":"Cancer Res"},{"issue":"17","key":"2019111903441765600_B63","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/onc.2015.280","article-title":"Wnt addiction of genetically defined cancers reversed by PORCN inhibition","volume":"35","author":"Madan","year":"2015","journal-title":"Oncogene"},{"issue":"24","key":"2019111903441765600_B64","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1073\/pnas.1508113112","article-title":"Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia","volume":"112","author":"Koo","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019111903441765600_B65","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.18632\/oncotarget.6742","article-title":"FZD7 regulates BMSCs-mediated protection of CML cells","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"17","key":"2019111903441765600_B66","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/0008-5472.CAN-10-0244","article-title":"FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells","volume":"70","author":"Gupta","year":"2010","journal-title":"Cancer Res"},{"issue":"8","key":"2019111903441765600_B67","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1158\/0008-5472.CAN-10-1495","article-title":"Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation","volume":"71","author":"Jin","year":"2011","journal-title":"Cancer Res"},{"issue":"8","key":"2019111903441765600_B68","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20120225","article-title":"Hematopoietic stem cell development requires transient Wnt\/\u03b2-catenin activity","volume":"209","author":"Ruiz-Herguido","year":"2012","journal-title":"J Exp Med"},{"issue":"9","key":"2019111903441765600_B69","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood-2014-09-598540","article-title":"Wnts are dispensable for differentiation and self-renewal of adult murine hematopoietic stem cells","volume":"126","author":"Kabiri","year":"2015","journal-title":"Blood"},{"key":"2019111903441765600_B70","first-page":"189","article-title":"Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond","volume-title":"Hematology Am Soc Hematol Educ Program","author":"Ahmed","year":"2013"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/8\/1008\/1465434\/blood714089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/8\/1008\/1465434\/blood714089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:45:03Z","timestamp":1574135103000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/8\/1008\/36353\/Enhanced-targeting-of-CML-stem-and-progenitor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,2,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-05-714089","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,23]]}}}